tiprankstipranks
FibroGen (FGEN)
NASDAQ:FGEN
Holding FGEN?
Track your performance easily

FibroGen (FGEN) Financial Statements

959 Followers

FibroGen Financial Overview

FibroGen's market cap is currently ―. The company's EPS TTM is $-1.229; its P/E ratio is -0.33; FibroGen is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 46.33M$ 50.64M$ 55.90M$ 27.14M$ 40.13M
Gross Profit$ 41.04M$ 45.46M$ 30.15M$ 21.73M$ 35.89M
EBIT$ -12.08M$ -11.02M$ -28.49M$ -51.70M$ -59.19M
EBITDA$ -11.34M$ -8.95M$ -27.67M$ -49.82M$ -56.81M
Net Income Common Stockholders$ -17.08M$ -14.26M$ -32.93M$ -56.23M$ -63.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 131.00M$ 140.71M$ 177.60M$ 235.59M$ 251.34M
Total Assets$ 264.42M$ 293.20M$ 365.87M$ 423.53M$ 460.43M
Total Debt$ 74.78M$ 146.38M$ 149.96M$ 152.55M$ 153.59M
Net Debt$ -56.22M$ 5.67M$ -27.64M$ -83.04M$ -97.75M
Total Liabilities$ 466.12M$ 483.58M$ 552.02M$ 585.73M$ 575.63M
Stockholders Equity$ -243.67M$ -232.34M$ -228.12M$ -204.17M$ -157.17M
Cash Flow-
Free Cash Flow$ -7.62M$ -39.88M$ -59.32M$ -18.57M$ -85.22M
Operating Cash Flow$ -8.38M$ -39.87M$ -59.29M$ -18.32M$ -84.54M
Investing Cash Flow$ 755.00K$ 72.24M$ 51.28M$ 10.24M$ 54.22M
Financing Cash Flow$ -127.00K$ 32.00K$ -165.00K$ -246.00K$ -22.00K
Currency in USD

FibroGen Earnings and Revenue History

FibroGen Debt to Assets

FibroGen Cash Flow

FibroGen Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis